These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26929976)

  • 1. Response.
    McDonald RJ; McDonald JS; Kallmes DF; Jentoft ME; Murray DL; Thielen KR; Williamson EE; Eckel LJ
    Radiology; 2015 Dec; 277(3):925. PubMed ID: 26929976
    [No Abstract]   [Full Text] [Related]  

  • 2. Gadolinium Deposition after Contrast-enhanced MR Imaging.
    Kanda T; Matsuda M; Oba H; Toyoda K; Furui S
    Radiology; 2015 Dec; 277(3):924-5. PubMed ID: 26599932
    [No Abstract]   [Full Text] [Related]  

  • 3. Intracranial Deposition of Intravenous Gadolinium Contrast: A Literature Review.
    Franco J
    Radiol Technol; 2017 Mar; 88(4):435-439. PubMed ID: 28298504
    [No Abstract]   [Full Text] [Related]  

  • 4. Gadolinium retention - 5 years later….
    Dillman JR; Davenport MS
    Pediatr Radiol; 2020 Feb; 50(2):166-167. PubMed ID: 31975183
    [No Abstract]   [Full Text] [Related]  

  • 5. Residual or retained gadolinium: practical implications for radiologists and our patients.
    Kanal E; Tweedle MF
    Radiology; 2015 Jun; 275(3):630-4. PubMed ID: 25942418
    [No Abstract]   [Full Text] [Related]  

  • 6. National Institutes of Health Perspective on Reports of Gadolinium Deposition in the Brain.
    Malayeri AA; Brooks KM; Bryant LH; Evers R; Kumar P; Reich DS; Bluemke DA
    J Am Coll Radiol; 2016 Mar; 13(3):237-41. PubMed ID: 26810815
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution and chemical forms of gadolinium in the brain: a review.
    Kanda T; Nakai Y; Hagiwara A; Oba H; Toyoda K; Furui S
    Br J Radiol; 2017 Nov; 90(1079):20170115. PubMed ID: 28749164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium depositions after the application of the hepatospecific gadolinium-based contrast agent gadoxetate disodium.
    Kim SY; Maurer MH; Richter JK; Heverhagen JT; Boehm IB
    Eur J Intern Med; 2018 Jan; 47():e9-e11. PubMed ID: 28965739
    [No Abstract]   [Full Text] [Related]  

  • 9. Gadolinium diffusion into orbital vitreous and aqueous humor, perivascular space, and ventricles in patients with chronic renal disease.
    Kanamalla US; Boyko OB
    AJR Am J Roentgenol; 2002 Nov; 179(5):1350-2. PubMed ID: 12388535
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of the Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging, Focusing in Part on Their Accumulation in the Brain and Especially the Dentate Nucleus.
    Runge VM
    Invest Radiol; 2016 May; 51(5):273-9. PubMed ID: 26945278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium Retention in the Body and Brain: Is It Time for an International Joint Research Effort?
    Quattrocchi CC; van der Molen AJ
    Radiology; 2017 Jan; 282(1):12-16. PubMed ID: 28005498
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of gadolinium-based magnetic resonance imaging contrast agents and awareness of brain gadolinium deposition among pediatric providers in North America.
    Mithal LB; Patel PS; Mithal D; Palac HL; Rozenfeld MN
    Pediatr Radiol; 2017 May; 47(6):657-664. PubMed ID: 28283727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium Deposition in Humans: When Did We Learn That Gadolinium Was Deposited In Vivo?
    Huckle JE; Altun E; Jay M; Semelka RC
    Invest Radiol; 2016 Apr; 51(4):236-40. PubMed ID: 26588463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium Deposition and Chronic Toxicity.
    Ramalho J; Ramalho M
    Magn Reson Imaging Clin N Am; 2017 Nov; 25(4):765-778. PubMed ID: 28964466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exceeding the limits of the normal blood-brain barrier: quo vadis gadolinium?
    Levy LM
    AJNR Am J Neuroradiol; 2007; 28(10):1835-6. PubMed ID: 17898191
    [No Abstract]   [Full Text] [Related]  

  • 16. NSF-active and NSF-inert species of gadolinium: mechanistic and clinical implications.
    Kuo PH
    AJR Am J Roentgenol; 2008 Dec; 191(6):1861-3. PubMed ID: 19020260
    [No Abstract]   [Full Text] [Related]  

  • 17. Free gadolinium is a likely trigger of nephrogenic systemic fibrosis.
    Abraham JL; Edward M
    AJR Am J Roentgenol; 2009 Oct; 193(4):W354; author reply W355. PubMed ID: 19770307
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of hepatobiliary gadolinium chelates for magnetic resonance imaging.
    Runge VM; Wells JW
    Acad Radiol; 1996 Aug; 3 Suppl 2():S455-7. PubMed ID: 8796628
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephrogenic systemic fibrosis: some considerations on the debate regarding its cause.
    Provenzale JM
    AJR Am J Roentgenol; 2008 Dec; 191(6):1867-9. PubMed ID: 19020262
    [No Abstract]   [Full Text] [Related]  

  • 20. Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function.
    Murata N; Gonzalez-Cuyar LF; Murata K; Fligner C; Dills R; Hippe D; Maravilla KR
    Invest Radiol; 2016 Jul; 51(7):447-53. PubMed ID: 26863577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.